TriMas Corporation (TRS)

TRS trades at $38.4, 53.6% above the near-term max pain of $25 expiring Oct 17, 2025 (19 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($20-$35), signaling increased put positioning or downside protection. Key magnetic zone at 25 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TRS shows a downward trend from 35 to 20, indicating bearish sentiment or hedging activity. The 57% spread signals divergent expectations across timeframes. Most levels below 38.4 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.